America's 10 Highest-Paid CEOs of 2011 (and How They Earned It)
The Richest Woman in the World: How Gina Rinehart Earns her Billions
Medical equipment giant Becton Dickinson's (NYSE: BDX) stock has meandered since recommended on March 17, 2009 at a price of $65.66, with volatility, most likely due to U.S. federal health care reform legislation uncertainty, but look for better quarters ahead, when the dust settles, which is why I'm reiterating my Buy rating for the company's shares. In FY2010, Becton's revenue growth should total about 5-7%, after essentially flat revenue in FY2009. Hospital spending cutbacks will hurt, but BDX will make up for the aforementioned with increased government orders, lower operating costs, and moderating raw material costs.
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
